Literature DB >> 2523522

Ontogeny of dopaminergic D-2 receptors in the rat nervous system: characterization and detailed autoradiographic mapping with [125I]iodosulpride.

N Sales1, M P Martres, M L Bouthenet, J C Schwartz.   

Abstract

[125I]Iodosulpride, a highly selective and sensitive probe for dopamine D-2 receptors, was used to study the expression of these receptors in binding studies performed on membranes and serial autoradiographic sections, throughout pre- and postnatal developmental periods. D-2 receptors were first detected autoradiographically in sensory and sympathetic ganglia at the embryonic age of 12 days, i.e. much earlier than in previous studies. In membrane binding studies, D-2 receptors were found to be modulated by guanylnucleotides as early as at embryonic day 15, suggesting that they were already functionally coupled to a regulatory G protein. The overall development of D-2 receptors in the central nervous system occurred according to a caudorostral gradient and was accompanied by a slightly but significantly increased affinity for dopamine, possibly related to the late expression of a D-2 receptor subclass. The ontogeny of D-2 receptors was compared to that of tyrosine hydroxylase immunoreactivity as reported by others and taken as an index of dopaminergic innervation. Despite some variations due to experimental conditions, this comparison resulted in the definition of various situations. In some major projection areas (e.g. caudate putamen at embryonic day 14) there was a simultaneous appearance of both dopaminergic markers whereas in most others (e.g. n. accumbens or olfactory tubercles at embryonic day 20) the appearance of D-2 receptors was preceded by 1-4 days by that of tyrosine hydroxylase immunoreactivity. However, in a few projection areas (e.g. the bed nucleus of the stria terminalis at embryonic day 21), D-2 receptors appeared 3-4 days earlier than tyrosine hydroxylase immunoreactivity. In areas of dopaminergic perikarya, e.g. substantia nigra and ventral tegmental area, where they largely correspond to somatodendritic autoreceptors, D-2 receptors appeared at embryonic days 17 and 21 respectively, i.e. 3-8 days after tyrosine hydroxylase immunoreactivity, suggesting that dopamine synthesis and release is not feedback regulated by autoreceptors at initial developmental stages. In areas where D-2 receptors are present in the absence of any established dopaminergic innervation (e.g. discrete layers of the hippocampus, cerebellum, parietal cortex or in cranial nerve nuclei), they generally appeared at a late stage, i.e. during the second or even the third postnatal week. Finally, there was transient and roughly concomitant expression of both D-2 receptors and tyrosine hydroxylase immunoreactivity in some areas such as spinal ganglia or the lateral ventricle floor, consistent with a possible development function of dopamine mediated by D-2 receptors.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2523522     DOI: 10.1016/0306-4522(89)90014-6

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  17 in total

1.  Brain-derived neurotrophic factor controls dopamine D3 receptor expression: implications for neurodevelopmental psychiatric disorders.

Authors:  Pierre Sokoloff; Olivier Guillin; Jorge Diaz; Patrick Carroll; Nathalie Griffon
Journal:  Neurotox Res       Date:  2002 Nov-Dec       Impact factor: 3.911

2.  Effects of prenatal exposure to methylmercury on dopamine-mediated locomotor activity and dopamine D2 receptor binding.

Authors:  Elisabetta Daré; Serguei Fetissov; Tomas Hökfelt; Håkan Hall; Sven Ove Ogren; Sandra Ceccatelli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-04-09       Impact factor: 3.000

3.  Differential autoreceptor control of somatodendritic and axon terminal dopamine release in substantia nigra, ventral tegmental area, and striatum.

Authors:  S J Cragg; S A Greenfield
Journal:  J Neurosci       Date:  1997-08-01       Impact factor: 6.167

4.  Ontogenetic differences in the psychopharmacological responses to separate and combined stimulation of D1 and D2 dopamine receptors during the neonatal to weanling age period.

Authors:  C A Moody; L P Spear
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 5.  Drugs, biogenic amine targets and the developing brain.

Authors:  Aliya L Frederick; Gregg D Stanwood
Journal:  Dev Neurosci       Date:  2009-04-17       Impact factor: 2.984

6.  Expression and function of dopamine receptors in the developing medial frontal cortex and striatum of the rat.

Authors:  S E Sillivan; C Konradi
Journal:  Neuroscience       Date:  2011-10-08       Impact factor: 3.590

Review 7.  Neurobehavioral evidence for changes in dopamine system activity during adolescence.

Authors:  Dustin Wahlstrom; Tonya White; Monica Luciana
Journal:  Neurosci Biobehav Rev       Date:  2009-12-21       Impact factor: 8.989

8.  Selective expression of dopamine D3 receptor mRNA in proliferative zones during embryonic development of the rat brain.

Authors:  J Diaz; S Ridray; V Mignon; N Griffon; J C Schwartz; P Sokoloff
Journal:  J Neurosci       Date:  1997-06-01       Impact factor: 6.167

Review 9.  Age matters.

Authors:  James Edgar McCutcheon; Michela Marinelli
Journal:  Eur J Neurosci       Date:  2009-03       Impact factor: 3.386

10.  Effects of acute dopamine depletion on responsiveness to D1 and D2 receptor agonists in infant and weanling rat pups.

Authors:  C A Moody; L P Spear
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.